Source: Annual Congress 2007 - Epithelial networks in the airways
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Bingle, F. Barnes, S. Cross, D. Rassl, W. Wallace, L. Bingle (Sheffield, Cambridge, Edinburgh, United Kingdom). Comparative expression of SPLUNC1 and LPLUNC1 in normal and cystic fibrosis lung. Eur Respir J 2007; 30: Suppl. 51, 1347

Member's Comments

No comment yet.

Related content which might interest you: Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 TLR-4 expression is reduced in cystic fibrosis bronchial epithelial cells Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction Source: Eur Respir J 2004; 23: 846-850 Year: 2004 Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients Source: Eur Respir J 2014; 44: 802-805 Year: 2014 The TLR4 regulator miR-21 is downregulated in the paediatric cystic fibrosis airway Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Do characteristic airway epithelial change precede the development of lung fibrosis? Ectopic epithelial marker protein expression in bleomycin induced fibrosis replicates that seen in bronchiolized epithelium in IPF Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012 Reduced bronchial epithelial Smad7 protein expression in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 3s Year: 2005 ANO1 expression and activity in cystic fibrosis Source: Annual Congress 2012 - New insights into airway epithelial cell physiology Year: 2012 Bronchial immunoglobulins and epithelial pIgR are upregulated in cystic fibrosis Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers Year: 2017 Increased cytokeratin-19 expression in fibrotic interstitial lung disease Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 MiRNA expression profile is altered upon cystic fibrosis pulmonary exacerbation Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Investigation of the status of cystic fibrosis airway epithelial cells Source: Annual Congress 2008 - Multigenic expression analyses: a guide for diagnosis and therapy Year: 2008 Microarray analysis reveals NFIB as a potential target of the matricellular protein WISP1 in alveolar epithelial cells in idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009 Peptide transport mechanisms in cystic fibrosis and normal human lung Source: Eur Respir J 2001; 18: Suppl. 33, 76s Year: 2001 Proteomics characterisation of nasal epithelial cells in cystic fibrosis Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Distribution and characterisation of lung mast cells in cystic fibrosis Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Expression of the nuclear factor-?B inhibitor A20 is altered in the cystic fibrosis epithelium Source: Eur Respir J 2013; 41: 1315-1323 Year: 2013 Function of PTEN/PI3k/AKT pathway in bronchioalveolar epithelium in the pathogenesis of lung fibrosis Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009